Estradiol valerate and estradiol valerate/dienogest (natazia) tablets: the first four-phasic oral contraceptive
Ndefo, U.Anadu.; Mosely, N.
P and T a Peer-Reviewed Journal for Formulary Management 35(11): 614-617
2010
ISSN/ISBN: 1052-1372 PMID: 21139816 Document Number: 215547
Document emailed within 1 workday
Related Documents
Caruso, S.; Agnello, C.; Romano, M.; Cianci, S.; Lo Presti, L.; Malandrino, C.; Cianci, A. 2011: Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life Journal of Sexual Medicine 8(10): 2841-2850Borgelt, L.M.; Martell, C.W. 2012: Estradiol valerate/dienogest: a novel combined oral contraceptive Clinical Therapeutics 34(1): 37-55
De Leo, V.; Fruzzetti, F.; Musacchio, M.C.; Scolaro, V.; Di Sabatino, A.; Morgante, G. 2013: Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism Contraception 88(3): 364-368
Nappi, R.E.; Serrani, M.; Jensen, J.T. 2014: Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature International Journal of Women's Health 6: 711-718
Grandi, G.; Xholli, A.; Napolitano, A.; Palma, F.; Cagnacci, A. 2015: Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study Reproductive Sciences 22(5): 626-632
Guida, M.; Bifulco, G.; Di Spiezio Sardo, A.; Scala, M.; Fernandez, L.Maria.Sosa.; Nappi, C. 2010: Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill International journal of women's health 2: 279-290
Molina, R.C.; Sandoval, J.Z.; Montero, A.V.; Oyarzún, P.G.; Molina, T.ís.G.; González, E.A. 2009: Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents Journal of Pediatric and Adolescent Gynecology 22(1): 25-31
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Graziottin, A. 2014: Contraception containing estradiol valerate and dienogest--advantages, adherence and user satisfaction Minerva Ginecologica 66(5): 479-495
Graziottin, A. 2014: Contraception containing estradiol valerate and dienogest--advantages, adherence and user satisfaction Minerva Ginecologica 66(5): 479-495
Jensen, J.T.; Parke, S.; Mellinger, U.; Machlitt, A.; Fraser, I.S. 2011: Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial Obstetrics and Gynecology 117(4): 777-787
Hauzman, E.E.; Zapata, A.; Bermejo, A.; Iglesias, C.; Pellicer, A.; Garcia-Velasco, J.A. 2013: Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial Reproductive Biology and Endocrinology: Rb&e 11: 96
Matiushin, A.I.; Kaverina, N.V.; Shimanovskiĭ, N.L.; Rzheznikov, V.M.; Turilova, A.I. 2003: Anti-arrhythmia activity of estradiol valerate and estradiol nitrate Eksperimental'naia i Klinicheskaia Farmakologiia 66(3): 26-28
2010: Estradiol + dienogest. Oral contraception: estradiol does not provide a therapeutic advantage Prescrire International 19(106): 65-67
Macìas, G.; Merki-Feld, G.S.; Parke, S.; Mellinger, U.; Serrani, M. 2013: Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY Ii study Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 33(6): 591-596
Manonai, J.; Chittacharoen, A.; Theppisai, U. 2004: Effect of estradiol valerate and levonorgestrel on vaginal health European Journal of Obstetrics Gynecology and Reproductive Biology 115(2): 190-193
Baweja, R.; Bhattacharya, S.K.; Choudhury, S.D.; Krishna, U.; Manuel, M.; Phillips, F.S.; Datey, S.; Kumar, S.; Mehta, S.; Saxena, N.C. 1985: Indian Council of Medical Research. Task Force on Hormonal Contraception: Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive Contraception 32(4): 383-394
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Hempel, E.; Illessy, G.; Schubert, K.H. 1987: Behavior the lipid spectrum following complete ovariectomy and subsequent substitution with estradiol valerate or norethisterone acetate Zentralblatt für Gynakologie 109(21): 1285-1289